Because we found that PRELID1P6 plays an oncogenic role in glioma and PRELID1P6 inhibited the ubiquitin-mediated degradation of hnRNPH1, we next investigated the impact of hnHNPH1 on glioma cell proliferation. This evidence concerns the gene HNRNPH1 and central nervous system cancer.